Stockscreener 앱 받기
3.75
3.59%
0.13
Sophia Genetics Sa 주식(SOPH)의 최신 뉴스
SPICE(spice 3) Latest NewsTargeted 200 Percent Gain - Newser
Why SOPHiA GENETICS SA stock attracts strong analyst attentionReal Chart Play - Newser
How CuriosityStream Inc. stock performs during market volatilityChart Breakout Alert - Newser
How Falcon s Beyond Global Inc. stock performs during market volatilityFree Best Performing Stock Suggestions - Newser
What makes SOPHiA GENETICS SA stock price move sharplyProven Trading Plan - Newser
Bradstreet Holdings Inc. stock attracts strong analyst attentionCapital Growth Picks - Newser
What makes IT Tech Packaging Inc. stock price move sharplyFree Long-Term Wealth Growth Plan - Newser
How SOPHiA GENETICS SA stock performs during market volatilityFree Stock Trading Community - Newser
When BANL stock expected to show significant growthIs STRL stock a good long term investment optionWeekly Double Return List - Newser
What makes SEZL stock price move sharplyFree Access to Investment Community - Newser
Turning Proof Into Power: Bioz Partners With SOPHiA GENETICS to Enhance Scientific Transparency via Custom Integration - Yahoo Finance
RELI cuts debt 50% after $5M Fortman sale; saves $1.8M annually | SOPH SEC FilingForm S-8 - Stock Titan
Revenues Tell The Story For SOPHiA GENETICS SA (NASDAQ:SOPH) As Its Stock Soars 29% - simplywall.st
SOPHiA GENETICS (NASDAQ:SOPH) Stock Price Up 8.7% – What’s Next? - Defense World
LOOP(loop x network) Price TodayDaily Volume Leaders - Newser
SOPHiA GENETICS Announces Key Approvals at 2025 Annual General Meeting - TipRanks
Precision Medicine Software Market Future Trends and Scope - openPR.com
Radiomics Market Key Players AnalysisRadiomics.io - openPR.com
SOPHiA GENETICS SA (NASDAQ:SOPH) Shares Sold by Squarepoint Ops LLC - Defense World
Innovation Fuels Rally for Tempus AI: Should You Buy the Stock Today? - sharewise
Bioinformatics Market Overview & Insights by 2032 - newstrail.com
Millennium Management LLC Increases Position in SOPHiA GENETICS SA (NASDAQ:SOPH) - Defense World
Dimensional Fund Advisors LP Has $68,000 Stock Holdings in SOPHiA GENETICS SA (NASDAQ:SOPH) - Defense World
Top Market Trend Impacting AI In Bioinformatics Development in the Coming Years: Bionl.AI Platform Revoluti... - WhaTech
After 92% YTD Surge, Is Tempus AI a Buy on Trump's Executive Order? - Yahoo Finance
SOPHiA GENETICS SA (NASDAQ:SOPH) Q1 2025 Earnings Call Transcript - Insider Monkey
SOPHiA GENETICS SA (SOPH) Reports Q1 Loss, Tops Revenue Estimates - MSN
SOPHiA GENETICS Q1 2025 Earnings Call Highlights - TipRanks
SOPHiA GENETICS First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
SOPHiA GENETICS SA 2025 Q1ResultsEarnings Call Presentation (NASDAQ:SOPH) - Seeking Alpha
SOPHiA GENETICS sets date for annual shareholder meeting - Investing.com Australia
SOPHiA GENETICS sets date for annual shareholder meeting By Investing.com - Investing.com South Africa
Sophia Genetics SA (SOPH) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Improved ... By GuruFocus - Investing.com Canada
SOPHiA GENETICS Reports Strong Q1 2025 Growth - TipRanks
SOPHiA GENETICS Q1 2025 Earnings Call Transcript - MarketBeat
SOPHiA GENETICS Reports Q1 2025 Financial Results - TipRanks
SOPH Hits Revenue and Margin Milestones in Q1 2024 | SOPH Stock News - GuruFocus
SOPHiA GENETICS Reports First Quarter 2025 Results - Quantisnow
Earnings To Watch: Sophia Genetics SA (SOPH) Reports Q1 2025 Result - Yahoo Finance
Sophia Genetics SA expected to post a loss of 25 cents a shareEarnings Preview - TradingView
Promising Penny Stocks To Consider In April 2025 - simplywall.st
Tempus AI Stock Surges 43% in Q1: Buy Now or Wait for Earnings? - The Globe and Mail
SOPHia Genetics expands testing partnership with AstraZeneca - MSN
SOPHiA Genetics (SOPH) Expands Liquid Biopsy Collaboration with AstraZeneca - GuruFocus
SOPHiA GENETICS Expands Global Collaboration With AstraZeneca To Advance Liquid Biopsy Testing - Nasdaq
SOPHiA GENETICS Announces Expanded Collaboration with AstraZeneca to Accelerate Liquid Biopsy Testing Globally from AACR – Company AnnouncementFT.com - Financial Times
SOPHiA GENETICS SA's (NASDAQ:SOPH) market cap touched US$204m last week, benefiting both individual investors who own 51% as well as institutions - simplywall.st
The Zacks Analyst Blog Highlights Tempus AI, AstraZeneca, iRhythm Technologies and SOPHiA GENETICS - Yahoo Finance
SOPHiA GENETICS to Announce Financial Results for First Quarter 2025 on May 6, 2025 - marketscreener.com
1.25%
0.96%
자본화:
|
볼륨(24시간):